At Market Issuance Sales AgreementPluristem Therapeutics Inc • December 26th, 2012 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 26th, 2012 Industry JurisdictionPluristem Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: